1.
Global economic burden of Chagas disease: a computational simulation model
by Lee, Bruce Y, Dr
The Lancet infectious diseases, 2013, Vol.13 (4), p.342-348
2.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
by Choueiri, Toni K, Dr
The lancet oncology, 2016, Vol.17 (7), p.917-927
3.
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis
by Salmon, Daniel A, Dr
The Lancet (British edition), 2013, Vol.381 (9876), p.1461-1468
